Table 3.
Risk of development of stent-related event increased with longer follow-up period in the absence of competing event (death)
Time-point of follow-up since first biliary stenting | Estimated risk of development of SRE rate for all patients |
3 mo | 11.5% (95%CI: 6.5-19.7) |
6 mo | 32.0% (95%CI: 23.5-42.7) |
12 mo | 48.6% (95%CI: 37.5-61) |
18 mo | 59.9% (95%CI: 44-76.5) |
24 mo | 79.9% (95%CI: 48.03-98.1) |
SRE: Stent-related event.